Soleno Therapeutics Inc. (SLNO) PT Lowered to $110 at Wells Fargo
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Nasdaq set for sharp drop as Amazon, Intel amplify AI spending worries
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil set for fourth monthly gain as Hormuz tanker attack highlights supply risks
Tweet
Share
E-mailGet Alerts SLNO Hot Sheet
Price: $53.01 --0%
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Rating Summary:
4 Buy, 10 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 43 | New: 7
Join SI Premium – FREE
Wells Fargo analyst Derek Archila lowered the price target on Soleno Therapeutics Inc. (NASDAQ: SLNO) to $110.00 (from $114.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Precision Drilling (PD:CN) (PDS) PT Raised to Cdn$170 at RBC Capital
- Textron (TXT) PT Raised to $94 at UBS
- WEX Inc. (WEX) PT Raised to $195 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
